Furthermore, αV/β5 integrin is also involved in the highly aggressive phenotype of melanoma cells such as cilengitide, an arginine–glycine–aspartic acid (RGD) broad-spectrum integrin inhibitor peptide [50], as well as reduced ECM invasion and the secretion of and MMP-9 by melanoma cells [51]. The gene discussed is MMP9; the disease is melanoma.